Article Information
PubMed
Published By
History
- Received August 28, 2016
- Revision received February 5, 2017
- Accepted February 8, 2017
- First published February 24, 2017.
- Version of record published March 22, 2017.
Copyright & Usage
Copyright © 2017 the authors 0270-6474/17/373294-17$15.00/0
Author Information
Author contributions
Author contributions: X.W., L.Z., and W.T.W. designed research; X.W., L.Z., Y.Z., W.M., and S.R.G. performed research; J.F., F.K., T.C.B., and H.Q. contributed unpublished reagents/analytic tools; X.W., L.Z., Y.Z., W.M., S.R.G., J.F., F.K., T.C.B., H.Q., and W.T.W. analyzed data; X.W., L.Z., Y.Z., W.M., J.F., H.Q., and W.T.W. wrote the paper.
Disclosures
- Received August 28, 2016.
- Revision received February 5, 2017.
- Accepted February 8, 2017.
This work was supported by funds from the National Eye Institute Intramural Research Program–National Institutes of Health.
A provisional patent for the use of tamoxifen for the treatment of retinal degenerations is currently being filed by the National Eye Institute, National Institutes of Health.
- Correspondence should be addressed to Wai T. Wong, Unit on Neuron-Glia Interactions in Retinal Disease, Building 6, Room 217, National Eye Institute, National Institutes of Health, Bethesda, MD 20892. wongw{at}nei.nih.gov
Other Version
- previous version (February 24, 2017).
- You are viewing the most recent version of this article.
Online Impact
